Show results for
Refine by
Mitral Regurgitation Suppliers Serving Germany
6 companies found
based inSanta Clara, ALABAMA (USA)
Abbott is dedicated to advancing structural heart therapies in collaboration with globally recognized specialists and care teams. The company's focus is on repairing the effects of structural heart diseases through innovative therapies that ...
The MitraClip™ G5 Transcatheter Edge-to-Edge Repair (TEER) system by Abbott is a sophisticated solution for treating mitral valve regurgitation (MR). It is particularly indicated for patients with symptomatic ...
based inKirkland, WASHINGTON (USA)
Heart failure is a progressive disease. It’s an expensive disease. It’s a devastating disease. Over 20% of heart failure patients with FMR die within the first year of diagnosis and 50% die within five years.1 Each year thousands of these patients ...
A completely different and much earlier approach to treating functional mitral regurgitation (FMR) than any other device therapy currently available to patients. The goal: Treat the condition—not just the ...
based inMaastricht, NETHERLANDS
For more than 20 years, Pie Medical Imaging has been dedicated to efficient and effective analysis and visualization of medical images. In cooperation with clinical and research partners , we develop state-of-the-art solutions for our customers ...
The Mitral Valve is a complex 3D structure. Mitral regurgitation can be treated by replacing the native valve (TMVR) or by repairing the native valve (TMVr). Planning for both types of procedures ...
based inMilano, ITALY
InnovHeart, with locations in Milan, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease. The company is currently in clinical trials testing its ...
The Mitral Valve is a complex structure positioned between the left atrium and the left ventricle. Its function is to make unidirectional the blood flow from the left atrium to the left ventricle. The Mitral Valve ...
based inSanta Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of ...
based inEpalinges, SWITZERLAND
Novostia is a privately held medical device company developing an innovative artificial heart valve, especially for young patients. With the support of world leading surgeons, Novostia endeavors to improve the quality of life of millions of patients ...